American Philip Morris International, the manufacturer of the cigarette brand Marlboro, reports an unexpectedly strong result for last year. Major support comes largely from the tobacco-free nicotine snuff Zyn.
The stock surges upwards by over 8 percent in futures trading on Wall Street after the report.
The operating result for the fourth quarter last year increased by 13 percent to 3.26 billion dollars, while net sales rose by over 7 percent to 9.71 billion dollars.
Deliveries of Zyn – part of Swedish Match, acquired by Philip Morris in 2022 – increased to almost 165 million doses in the fourth quarter, an increase of 42 percent compared to the corresponding quarter last year.
The successes of Zyn have prompted the group to invest in a new factory in the state of Colorado, and the forecast is for continued growth to 780-820 million doses in sales next year.
